Literature DB >> 689572

The cytotoxic and cytocidal effect of colicin E3 on mammalian tissue cells.

J Smarda, V Obdrzálek, I Táborský, J Mach.   

Abstract

The plasma membrane of mammalian cells can mediate the cytotoxic and cytocidal effects of colicin E3. As little as 10(2) lethal units of purified colicin E3 per cell exert a pronounced cytocidal effect on human epithelial HeLa cells and as little as 10(4) lethal units per cell also on line L mouse fibroblasts in tissue culture. Cells in complete monolayers are rapidly killed, become spherical and shrink, they are detached from the support and finally autolyzed. The percentage of killed cells in both lines is directly proportional to the multiplicity of colicin used. The LD50 for HeLa cells is about 30 times lower than for L cells. At the multiplicity of 10(5) I.u., usually 100% HeLa and 90% L cells are killed in 2--3 days. Purified colicins E2 and D have no demonstrable cytological effect on HeLa cells, although DNA synthesis in L cells appears to be partly inhibited by colicin E2. The profound effect of colicin E3 on mammalian cells could be interpreted in a similar way as in bacteria, viz. as a specific cleavage of rRNA.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 689572     DOI: 10.1007/BF02876680

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  13 in total

1.  Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia.

Authors:  H Farkas-Himsley; R Cheung
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

2.  Dissociating activity of purified colicin E 2 on the isolated DNA-membrane complex of Escherichia coli.

Authors:  T Beppu; K Arima
Journal:  Biochim Biophys Acta       Date:  1972-04-12

3.  Effects of colicin K on a mutant of Escherichia coli deficient in Ca 2+, Mg 2+-activated adenosine triphosphatase.

Authors:  C A Plate; J L Suit; A M Jetten; S E Luria
Journal:  J Biol Chem       Date:  1974-10-10       Impact factor: 5.157

4.  Dissociating activity of purified colicin E2 on the isolated membrane complex of Escherichia coli.

Authors:  T Beppu; K Arima
Journal:  Biochim Biophys Acta       Date:  1970-12-01

5.  The effect of colicin E2 on the flagellate Euglena gracilis.

Authors:  J Smarda; L Ebringer; J Mach
Journal:  J Gen Microbiol       Date:  1975-02

6.  Conserved terminal sequence in 18SrRNA may represent terminator anticodons.

Authors:  L Dalgarno; J Shine
Journal:  Nat New Biol       Date:  1973-10-31

7.  [Study of the tensio-active power of some proteins-bacteriocins].

Authors:  Y Hamon; Y Peron
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1974-05-06

8.  Effects of colicins E1 and K on cellular metabolism.

Authors:  K L Fields; S E Luria
Journal:  J Bacteriol       Date:  1969-01       Impact factor: 3.490

9.  Purification and characterization of colicin D.

Authors:  K Timmis
Journal:  J Bacteriol       Date:  1972-01       Impact factor: 3.490

10.  Highly purified colicin E3 contains immunity protein.

Authors:  K S Jakes; N D Zinder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

View more
  7 in total

1.  Cytotoxic effects of colicins E1-E5 and K on hamster fibroblasts.

Authors:  J Smarda; J Keprtová
Journal:  Folia Microbiol (Praha)       Date:  1987       Impact factor: 2.099

2.  Effect of colicin E3 on leukemia cells P388 in vitro.

Authors:  J Fuska; A Fusková; J Smarda; J Mach
Journal:  Experientia       Date:  1979-03-15

Review 3.  Colicins--exocellular lethal proteins of Escherichia coli.

Authors:  J Smarda; D Smajs
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

4.  Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia.

Authors:  Darina Kohoutova; David Smajs; Paula Moravkova; Jiri Cyrany; Monika Moravkova; Miroslava Forstlova; Michal Cihak; Stanislav Rejchrt; Jan Bures
Journal:  BMC Infect Dis       Date:  2014-12-24       Impact factor: 3.090

Review 5.  Bacterial-Based Methods for Cancer Treatment: What We Know and Where We Are.

Authors:  Foad Rommasi
Journal:  Oncol Ther       Date:  2021-11-15

6.  Human tumor cells are selectively inhibited by colicins.

Authors:  J Chumchalová; J Smarda
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.629

Review 7.  Bacteriocins as Potential Anticancer Agents.

Authors:  Sumanpreet Kaur; Sukhraj Kaur
Journal:  Front Pharmacol       Date:  2015-11-10       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.